# Determine Return on Investment in Heart Failure Remote Monitoring Program

Study · id `cardio:ct-nct02475577` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02475577](<https://clinicaltrials.gov/study/NCT02475577>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02475577

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 163 participants.

## Technical summary

Registry record NCT02475577. Randomized; single masking; primary purpose prevention. Start 2015-06 (registry gives no type); primary completion 2017-06 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 163 participants (planned count; ClinicalTrials.gov record NCT02475577, source copy `cardio:ctgov-nct02475577-2016-03-31`, retrieved 2026-10-26)
- Start date: 2015-06 (registry gives no type) (ClinicalTrials.gov record NCT02475577, source copy `cardio:ctgov-nct02475577-2016-03-31`, retrieved 2026-10-26)
- Primary completion: 2017-06 (anticipated) (ClinicalTrials.gov record NCT02475577, source copy `cardio:ctgov-nct02475577-2016-03-31`, retrieved 2026-10-26)
- Completion: 2017-08 (anticipated) (ClinicalTrials.gov record NCT02475577, source copy `cardio:ctgov-nct02475577-2016-03-31`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT02475577, source copy `cardio:ctgov-nct02475577-2016-03-31`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02475577-2016-03-31`, retrieved 2026-10-26)

## The registry's words

- Brief title: Determine Return on Investment in Heart Failure Remote Monitoring Program
- Condition: Heart Failure
- Intervention (Device): Peripherals with HealthInterlink technology
- Lead sponsor: NCH Healthcare System, Inc. dba Naples Comprehensive Health and dba NCH
- Lead sponsor class: OTHER
- Collaborator: Welch Allyn
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)

## Provenance

Content hash: c44777c345097b46b13556b5f326884edc8271928db2404658cc83b749b79920
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
